22 Feb 2019

52 Wk Range: 0.142 - 0.265

Day's Range: 0.245 - 0.25

Last Volume: 204,500

Last Close: SGD 0.245

Current Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

22 Feb 2019

Metric	42C	S.Median
Beta	0.38	0.26
VaR	37.72	37.72
E.Shortfall	46.06	53.97
Liquidity	80.42K	30.76K

21 Feb 2019

PE: NA

Market Cap: 164.4M

Price Over Book: 10.412

Price Over Sales: 24.97

Return On Assets: -49.8%

Return On Equity: -68.4%

NAV Over Price: [Friends Only]

[Members Only]

Sign up for free to access most features of StocksCafe

[Members Only]

Sign up for free to access most features of StocksCafe

iX Biopharma Ltd. engages in the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, as well as male erectile dysfunction. It operates through the following segments: Specialty Pharmaceutical, Chemical Analysis, and Nutraceutical. The Specialty Pharmaceutical segment manufactures and sells pharmaceutical products. The Chemical Analysis segment provides laboratory testing services. The Nutraceutical segment offers nutraceutical products. The company was founded by Lee Yip Hang on May 8, 2004 and is headquartered in Singapore.

CEO: Yip Hang Lee

Founded Year: 2004

Headquarters: Singapore

Shares Outstanding: 644.6M

Security Type: Stock

Sector: Health Technology

Industry: Pharmaceuticals: Other

Useful Links
Homepage